◦ A higher standard for at-home ketamine

Ketamine therapy that earns its place in real medicine.

At-home ketamine has a credibility problem. Trellis fixes it — pairing the convenience of home dosing with the clinical rigor of a supervised psychiatric program. Not an app that mails you medicine. A treatment program that happens to reach your home.

The stakes

Convenience without oversight is how people get hurt.

The first wave of direct-to-consumer telehealth ketamine made a powerful medicine available to people who needed it. It also stripped away most of the structure that makes psychiatric ketamine safe: the in-person evaluation, the supervised first doses, the vital sign monitoring, the doctor who actually knows you.

That gap is now the subject of national scrutiny, regulatory attention, and litigation. The medicine was never the problem. The missing structure was.

Trellis is built on a simple premise: a patient should never take their first dose of ketamine alone, and should never take a dose at home without a real clinician standing behind the treatment.
The model

Three phases. Earned, not skipped.

Most telehealth ketamine starts you at home on day one. Trellis earns its way to your living room — through the clinic first.

1

In-Person Evaluation

Begins in the clinic

A complete psychiatric evaluation, in person, with the prescribing physician. This establishes the medical relationship the law requires for ongoing controlled-substance care — and it means your doctor has actually met you.

  • Comprehensive diagnostic assessment
  • Medical screening & EKG where indicated
  • Documented informed consent
2

Supervised Induction

Your first doses, in clinic

Your first ketamine sessions happen in the clinic, in a monitoring chair, with vital signs tracked throughout. We learn how your body responds before you ever dose at home — and calibrate your dose to you, not to an algorithm.

  • Continuous medical monitoring
  • Individualized dose titration
  • Response & tolerability confirmed
3

At-Home Maintenance

Home, with a safety net

Only after you've been evaluated and stabilized do you transition home — and never alone. A vetted peer monitor is present for every session, your vitals are recorded, and a clinician reviews every dose.

  • Trained, ID-verified peer monitor present
  • Blood pressure tracked each session
  • Physician reviews every session
The difference

Where the structure holds — and where it doesn't.

An honest comparison between standard direct-to-consumer telehealth ketamine and a Trellis-based program.

Typical model
DTC telehealth ketamine
Trellis standard
Our model
Trellis program
Initial evaluation
Video intake, often 15–30 minutes
In-person comprehensive psychiatric evaluation
Legal basis for prescribing
Temporary COVID-era telehealth flexibilities
Permanent in-person exemption — durable footing
First doses
Self-administered at home, day one
Supervised in clinic with medical monitoring
Dose calibration
Standardized / algorithmic
Individually titrated under observation
Peer monitor vetting
Self-attested by the patient, minimal checks
ID-verified + video interview + signed consent
Vital sign monitoring
Optional or unrecorded
Blood pressure at 3 protocol intervals
Physician oversight per session
Minimal to none after shipment
Every session reviewed within 48 hours
Crisis coverage during dosing
Variable; often unstaffed
On-call clinician every dosing window
Re-evaluation cadence
Infrequent or questionnaire-only
In-person every 90 days
Your prescriber
Often rotating or anonymous
One named psychiatrist who knows you
Medication traceability
Limited
Full lot tracking & adverse-event reporting
Operating scope
National, high-volume, low-touch
State-licensed, low-volume, high-touch
For patients

You deserve a real doctor, not a drop-shipment.

  • A psychiatrist who knows your name

    The same physician evaluates you, treats you, and follows your progress — not a rotating panel of strangers.

  • You're never alone for a dose

    Your first sessions are in the clinic. At home, a trained peer monitor is present every single time.

  • Someone is always reachable

    A clinician is on call during every dosing window. If something feels wrong, help is one tap away.

  • We check on you, every time

    Your vitals and your response are reviewed after each session — so your treatment adjusts to how you're actually doing.

For providers

A model you can defend — clinically and legally.

  • Built on durable legal footing

    The in-person evaluation exemption — not temporary telehealth flexibilities that may not survive the next regulatory cycle.

  • Documentation for every dose

    Vitals, attestations, peer monitor records, and your sign-off — a complete, time-stamped, immutable record on every session.

  • Risk surfaced, not buried

    Out-of-range vitals and adverse events auto-flag for your review. Nothing waits in an inbox you didn't know to check.

  • Oversight that scales with you

    Run a rigorous program without drowning in it. Trellis handles the orchestration so you can handle the medicine.

The safety architecture

Six structures that make home dosing defensible.

Vetted peer monitor

Every monitor is ID-verified, interviewed by video, and signs a consent that spells out their responsibilities and the escalation criteria.

Protocol vital monitoring

Blood pressure at baseline, peak, and recovery. Readings outside safe thresholds halt dosing or trigger immediate clinical contact.

Per-session attestation

A structured record captured live during each session — vitals, observations, patient response — locked and queued for physician review.

On-call coverage

A clinician is reachable for the entire dosing window. A tiered escalation ladder routes concerns to the right responder, fast.

90-day re-evaluation

Recurring in-person review keeps the treatment relationship current and on durable legal footing — and catches drift before it becomes risk.

Lot traceability

Every dose is tied to a specific compounded lot — so a recall, an adverse event, or an audit can be answered in minutes, not days.

Run the program the right way — without building it yourself.

Trellis gives psychiatric practices the infrastructure to deliver at-home ketamine therapy with clinic-grade oversight. Request access and see the platform.

Talk to us

See Trellis with your own protocols

Tell us about your practice and we'll set up a 45-minute working session — not a sales pitch. We'll walk through evaluation, supervision, peer-monitor verification, and billing against your actual workflow.

  • One business day reply — from a clinical operator, not an SDR.
  • No card, no commitment — pilot a single program first, expand only if it fits.
  • HIPAA-aligned from day one — BAA, audit log, role-based access standard.

We reply within one business day. No demos without your sign-off.

FAQ

Common questions

Eligibility, supervision, peer monitors, and billing — the questions practices ask before going live on Trellis.

Important: Ketamine is not FDA-approved for the treatment of depression or other psychiatric conditions; its use in these contexts is off-label. Compounded ketamine is not FDA-evaluated for safety or efficacy. Treatment is appropriate only for select patients following a comprehensive evaluation by a licensed physician. Trellis is clinical infrastructure software for licensed practices; it does not provide medical care or prescribe medication. Comparisons describe general characteristics of direct-to-consumer telehealth ketamine programs as a category and are not directed at any specific provider.